These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36214002)

  • 1. Excretion of Amyloid-β in the Gastrointestinal Tract and Regulation by the Gut Microbiota.
    Wu S; Hu L; Lin J; Li K; Ye S; Zhu S; Liu Z
    J Alzheimers Dis; 2022; 90(3):1153-1162. PubMed ID: 36214002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of gut microbiota and plasma amyloid-β as a potential index for identifying preclinical Alzheimer's disease: a cross-sectional analysis from the SILCODE study.
    Sheng C; Yang K; He B; Du W; Cai Y; Han Y
    Alzheimers Res Ther; 2022 Feb; 14(1):35. PubMed ID: 35164860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-gastrointestinal amyloid-β1-42 oligomers perturb enteric function and induce Alzheimer's disease pathology.
    Sun Y; Sommerville NR; Liu JYH; Ngan MP; Poon D; Ponomarev ED; Lu Z; Kung JSC; Rudd JA
    J Physiol; 2020 Oct; 598(19):4209-4223. PubMed ID: 32617993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-targeted magnetic mesoporous silica nanoparticles reduce brain amyloid-β burden via depolymerization and intestinal metabolism.
    Liu N; Liang X; Yang C; Hu S; Luo Q; Luo H
    Theranostics; 2022; 12(15):6646-6664. PubMed ID: 36185606
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model.
    Kim MS; Kim Y; Choi H; Kim W; Park S; Lee D; Kim DK; Kim HJ; Choi H; Hyun DW; Lee JY; Choi EY; Lee DS; Bae JW; Mook-Jung I
    Gut; 2020 Feb; 69(2):283-294. PubMed ID: 31471351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-β 1-24 C-terminal truncated fragment promotes amyloid-β 1-42 aggregate formation in the healthy brain.
    Mazzitelli S; Filipello F; Rasile M; Lauranzano E; Starvaggi-Cucuzza C; Tamborini M; Pozzi D; Barajon I; Giorgino T; Natalello A; Matteoli M
    Acta Neuropathol Commun; 2016 Oct; 4(1):110. PubMed ID: 27724899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity.
    Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H
    Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
    Ma Q; Zhao Z; Sagare AP; Wu Y; Wang M; Owens NC; Verghese PB; Herz J; Holtzman DM; Zlokovic BV
    Mol Neurodegener; 2018 Oct; 13(1):57. PubMed ID: 30340601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic-induced gut microbiota depletion from early adolescence exacerbates spatial but not recognition memory impairment in adult male C57BL/6 mice with Alzheimer-like disease.
    Mosaferi B; Jand Y; Salari AA
    Brain Res Bull; 2021 Nov; 176():8-17. PubMed ID: 34391822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive benefits of lithium chloride in APP/PS1 mice are associated with enhanced brain clearance of β-amyloid.
    Pan Y; Short JL; Newman SA; Choy KHC; Tiwari D; Yap C; Senyschyn D; Banks WA; Nicolazzo JA
    Brain Behav Immun; 2018 May; 70():36-47. PubMed ID: 29545118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State.
    Shen L; Liu L; Ji HF
    J Alzheimers Dis; 2017; 56(1):385-390. PubMed ID: 27911317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations.
    Youmans KL; Leung S; Zhang J; Maus E; Baysac K; Bu G; Vassar R; Yu C; LaDu MJ
    J Neurosci Methods; 2011 Mar; 196(1):51-9. PubMed ID: 21219931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer's disease.
    Qian XH; Liu XL; Chen G; Chen SD; Tang HD
    J Neuroinflammation; 2022 Sep; 19(1):236. PubMed ID: 36171620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive Spatial Memory Impairment, Brain Amyloid Deposition and Changes in Serum Amyloid Levels as a Function of Age in APPswe/PS1dE9 Mice.
    Fu L; Sun Y; Guo Y; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
    Curr Alzheimer Res; 2018; 15(11):1053-1061. PubMed ID: 29984654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
    Sun M; Ma K; Wen J; Wang G; Zhang C; Li Q; Bao X; Wang H
    J Alzheimers Dis; 2020; 73(3):849-865. PubMed ID: 31884474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Donepezil Treatment on Brain Metabolites, Gut Microbiota, and Gut Metabolites in an Amyloid Beta-Induced Cognitive Impairment Mouse Pilot Model.
    Jo JK; Lee G; Nguyen CD; Park SE; Kim EJ; Kim HW; Seo SH; Cho KM; Kwon SJ; Kim JH; Son HS
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
    Mitani Y; Yarimizu J; Akashiba H; Shitaka Y; Ni K; Matsuoka N
    J Neurochem; 2013 May; 125(3):465-72. PubMed ID: 23240999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.